EHCO

Ehco is a Danish biotechnology company specializing in the isolation and high-resolution analysis of extracellular vesicles (EVs). The company's core technology is a proprietary nano-fluidic platform designed to overcome the limitations of current EV characterization methods by enabling single-vesicle analysis at high throughput. This platform allows for the precise measurement of EV size, concentration, and surface protein expression, which is critical for the development of next-generation liquid biopsies and EV-based therapeutics. Ehco's mission is to provide researchers and clinicians with the tools necessary to harness EVs for early disease detection and personalized medicine. The company primarily targets applications in oncology, neurology, and cardiology.